Pune, India -- (SBWire) -- 04/12/2019 --The global Immunoassay Market is anticipated to grow at a constant CAGR around 4.9 % during the forecast period 2018 to 2026 and reach the market value around USD 26.1 billion by 2026.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1277

According to the report named "Immunoassay Market - Global Industry Analysis, Growth, Share, Size, Trends and Forecast, 2018-2026". The primary driving factor of development is extensive use of immunoassay techniques to detect infectious and chronic diseases. In addition, it is anticipated that new products will also be launched along with rapid technological developments. For example, the 2018 CE mark for its Sofia product, which is a QV assay used for the Sofia instrument, was approved for Quidel Corporation. In the field of immunoassay techniques, such as radiological immunosubsidization, rapid testing and immunoassays, the collaborations and partnerships among medical device giants should be developed.

Automation also has advantages such as efficiency and optimum laboratory use. The immune support market is therefore experiencing lucrative growth as some players introduce automated laboratory systems, compact test points and portable tests. For example: launch of Boditech Med, Inc., an FDA-approved fluorescence scanning tool for influenza testing, for innovative products, such as Compact and Portable I chroma II.

Infectious disease testing led the market in 2018

The market was led by testing for infectious diseases in 2018. The increase in the prevalence can be attributed to infectious diseases such as TB, Lyme disease, infections of salmonella or meningococcal disease. In 2017, for example, more than 10 million tuberculosis cases have been registered globally and approximately 1.3 million deaths have been caused by the Centers for Disease Control and Prevention (CDC). The use of immunoassays therefore would help detect these diseases, which are expected to increase demand in the market.

Oncology, due to the increased number of cancer cases and technological advances that help to identify malignant organisms, is expected to be the fastest growing sector during the forecast period. For example, the predominance of cancer in the whole world is increasingly reduced by tumor biomarkers and tests. Tumor biomarkers play a major role in the care of cancer, from identification, screening, and detection to progression monitoring.

The increase in the incidence of endocrinal disorders leads to increased hospital admissions and also holds a significant market share in endocrinology. For example, in 2017, around 210,000 individuals in the U.S. were admitted every year because of acute pancreatitis, according to the Johns Hopkins Health System Corporation. Moreover, around 40 million people in the country are also affected by osteoporosis.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/immunoassay-market

End-User Stance

Hospitals represented approximately 32.0 percent of the largest market share in 2018 because they offer advanced facilities including in-house diagnostic labs. The need for hospitals and diagnostic centers for antigen detection in cell cancer has increased with increasing the prevalence of chronic diseases such as cancer, infectious diseases, and autoimmune diseases. This factor will bode well in the near future for segment growth.

North America is expected to dominate the Immunoassay Market

Substantial market share for North America in 2018 was attributed to high investment in R&D by manufacturers of pharmaceutical and medical devices as well as favorable government policies. For example, in May 2018 a US Congress bill authorizing a person to test unsuccessful medical devices including medicines, medicines, and devices in cases of severe disease was approved.

The growth of disposable income and health spending in the emerging economies such as India, South Korea, and China in the Asia Pacific is expected to be lucrative in the coming years. Furthermore, the increased use of medical devices will also help to build lucrative opportunities in countries like South Korea. For example, on 15 March 2012, a duty-free agreement was signed in Korea on medical devices.

Thermo Fisher Scientific, Inc., Siemens Healthineers are Likely to Continue to Lead the Global Immunoassay Market

The Immunoassay market is consolidated with a large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview, and revenues. The key players of the market are Dickinson & Company; Becton, Thermo Fisher Scientific, Inc.; BioMérieux; Siemens Healthineers; Abbott Laboratories; Roche Diagnostics; Sysmex Corporation; Danaher Corporation; Ortho-Clinical Diagnostics; and Quidel Corporation.

Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Immunoassay
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Immunoassay Market By Technology
1.2.2.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Immunoassay Market Revenue Share By Technology in 2017
1.2.2.3. Enzyme Immunoassay (EIA)
1.2.2.3.1. Fluorescence Immunoassays (FIA)
1.2.2.3.2. Chemiluminescence Immunoassays (CLIA)
1.2.2.4. Radioimmunoassay (RIA)
1.2.2.5. Rapid test
1.2.2.6. Others
1.2.3. Immunoassay Market By Product
1.2.3.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Global Immunoassay Market Revenue Share By Product in 2017
1.2.3.3. Analyzers/instruments
1.2.3.3.1. Closed ended systems
1.2.3.3.2. Open ended systems
1.2.3.4. Reagents & kits
1.2.3.5. Software & services
1.2.3.6. Others
1.2.4. Immunoassay Market By Application
1.2.4.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Immunoassay Market Revenue Share By Application in 2017
1.2.4.3. Endocrinology
1.2.4.4. Therapeutic drug monitoring
1.2.4.5. Autoimmune diseases
1.2.4.6. Infectious disease testing
1.2.4.7. Cardiology
1.2.4.8. Others
1.2.5. Immunoassay Market By End-Use
1.2.5.1. Global Immunoassay Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.5.2. Global Immunoassay Market Revenue Share By End-Use in 2017
1.2.5.3. Hospitals
1.2.5.4. Pharmaceutical and biotech companies
1.2.5.5. Clinical laboratories
1.2.5.6. Academic research centers
1.2.5.7. Blood banks
1.2.5.8. Others
1.2.6. Immunoassay Market by Geography
1.2.6.1. Global Immunoassay Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Immunoassay Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Immunoassay Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Immunoassay Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Immunoassay Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Immunoassay Major Manufacturers in 2017

CHAPTER 4. Immunoassay Market By Technology

4.1. Global Immunoassay Revenue By Technology
4.2. Enzyme Immunoassay (EIA)
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Fluorescence Immunoassays (FIA)
4.2.4. Chemiluminescence Immunoassays (CLIA)
4.3. Radioimmunoassay (RIA)
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Rapid test
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Immunoassay Market By Product

5.1. Global Immunoassay Revenue By Product
5.2. Analyzers/instruments
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. Closed ended systems
5.2.4. Open ended systems
5.3. Reagents & kits
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Software & services
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Immunoassay Market By Application

6.1. Global Immunoassay Revenue By Application
6.2. Endocrinology
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Therapeutic drug monitoring
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Autoimmune diseases
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Infectious disease testing
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Cardiology
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Others
6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Immunoassay Market By End-Use

7.1. Global Immunoassay Revenue By End-Use
7.2. Hospitals
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Pharmaceutical and biotech companies
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Clinical laboratories
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Academic research centers
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Blood banks
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Others
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. North America Immunoassay Market By Country

8.1. North America Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
8.3.1. U.S. Immunoassay Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. Europe Immunoassay Market By Country

9.1. Europe Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. Asia-Pacific Immunoassay Market By Country

10.1. Asia-Pacific Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. Latin America Immunoassay Market By Country

11.1. Latin America Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. Middle East Immunoassay Market By Country

12.1. Middle East Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 13. Africa Immunoassay Market By Country

13.1. Africa Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Immunoassay Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. Dickinson & Company
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Becton
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. BioMérieux
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Siemens Healthineers
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Abbott laboratories
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Roche Diagnostics
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. Sysmex Corporation
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Danaher Corporation
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies
14.10. Ortho Clinical Diagnostics
14.10.1. Company Snapshot
14.10.2. Overview
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Key Developments
14.10.6. Strategies
14.11. Quidel Corporation
14.11.1. Company Snapshot
14.11.2. Overview
14.11.3. Financial Overview
14.11.4. Product Portfolio
14.11.5. Key Developments
14.11.6. Strategies
14.12. Others
14.12.1. Company Snapshot
14.12.2. Overview
14.12.3. Financial Overview
14.12.4. Product Portfolio
14.12.5. Key Developments
14.12.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1277

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1277

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.